Notch signal transduction is mediated by proteolysis of the receptor and translocation of the intracellular domain (IC) into the nucleus, where it functions as a regulator of HES gene expression after binding to the DNA-binding protein RBP-Jk.
Introduction
The Notch signaling pathway is important for the control of cellular differentiation in many different organs, including muscle, nervous system, immune system and pancreas (Artavanis-Tsakonas et al., 1999) . Work from¯ies, nematodes and vertebrates has contributed to our current understanding of the signaling mechanism. The single transmembrane spanning Notch receptor undergoes a complicated set of processing events during intracellular traf®cking and at the cell surface (for review see Brown et al., 2000; Kadesch, 2000) . It is ®rst cleaved at the extracellular side by a furin-like convertase during transport in the Golgi compartment. In response to interaction with ligands on neighboring cells, a second cleavage occurs at the extracellular side close to the plasma membrane (Brou et al., 2000; Mumm et al., 2000;  for review see Brown et al., 2000) . This is a prerequisite for a ®nal proteolytic cleavage at the intracellular side of the plasma membrane (Schroeter et al., 1998) . The protease responsible for the ligandinduced intracellular cleavage has not yet been identi®ed, but this process is controlled by presenilins, since cleavage is strongly reduced in the absence of presenilins (De Strooper et al., 1999; Struhl and Greenwald, 1999; Ye et al., 1999) . This sequential cleavage, i.e. ®rst at the extracellular side and then in or close to the plasma membrane, is not unique to Notch. The activity of an increasing number of both eukaryotic and prokaryotic proteins is controlled in this manner, a process dubbed`regulated intramembrane proteolysis' or RIP (Brown et al., 2000) .
After cleavage, the Notch intracellular domain (IC), which has two nuclear translocation signals, translocates to the nucleus. In the nucleus, the Notch IC interacts with the DNA-binding protein RBP-Jk (also called CBF or CSL). The activation of downstream genes, called HES genes in mammals and Enhancer of Split in Drosophila, as a result of Notch IC and RBP-Jk interactions appears to be the most Mechanisms of Development 104 (2001) 3±20 important mechanism to transduce the Notch signal (Artavanis-Tsakonas et al., 1999) . Activation of HES-like genes can be considered as the`classical' Notch signaling and is supported by data from Drosophila and Xenopus Notch, and from observations from mammalian Notch 1 and 2 (for review see Kadesch, 2000) . A wealth of data from various model systems show that the Notch IC is a gain-of-function, ligand-independent version of a Notch receptor (Rebay et al., 1993; Struhl et al., 1993) , and engineered Notch ICs can therefore be used experimentally to mimic an activated Notch receptor. There are, however, some aspects of Notch signaling that have been attributed to effects that do not require interaction with RBP-Jk (Shawber et al., 1996) , although the molecular basis for this is less well understood.
The mechanism by which Notch IC activates transcription as a result of interaction with RBP-Jk is not completely understood. In the absence of Notch, RBP-Jk acts as a repressor of transcription (Dou et al., 1994; Hsieh and Hayward, 1995) . It recruits a histone deacetylase (HDAC) co-repressor complex to the promoter, and it was recently shown that RBP-Jk binds the co-repressor SMRT (Hsieh et al., 1999; Kao et al., 1998) . RBP-Jk is linked to the HDACs by the co-repressors SMRT, CIR and SAP30 and by HDAC 1 (Hsieh et al., 1999; Kao et al., 1998) . The Notch 1 IC can displace SMRT and interact with RBP-Jk to activate transcription from the HES promoter (Kao et al., 1998) . The recently discovered protein SKIP plays an important role in the interactions between Notch IC and RBP-Jk, and Notch IC and SMRT can bind in a mutually exclusive manner to SKIP (Zhou et al., 2000) . Other proteins, like EBNA2, act in concert with RBP-Jk to induce transcription from speci®c promoters (Henkel et al., 1994; Zimber-Strobl et al., 1994) . RBP-Jk may also mediate repression on another level, by interfering with TFIIA and TFIID of the basal transcription machinery (Olave et al., 1998) .
The Notch IC is composed of different domains: RAM, ankyrin repeats and a C-terminal region containing a glutamine-rich region (OPA) and PEST sequences. The role of the individual regions in signaling is not clear. The RAM domain has been suggested to be the major interface of Notch IC in binding to RBP-Jk Tamura et al., 1995) . In other assays, however, it appears to be dispensable for Notch IC activity (Aster et al., 1997; Shawber et al., 1996; Wettstein et al., 1997) . The ankyrin repeats in the C. elegans Notch homologue GLP-1 have been suggested to contain a transactivation domain (Roehl et al., 1996) , whereas studies of the mammalian Notch 1 IC indicate that it is responsible for displacing a co-repressor (Kurooka et al., 1998) . The ankyrin repeat region also possesses a weak RBP-Jk binding domain (Tamura et al., 1995) . It has been described that Notch 1 and 2 ICs as well as Drosophila Notch IC contain transactivation domains in the C-terminal domain (Kidd et al., 1998; Kurooka and Honjo, 2000; Kurooka et al., 1998) . In contrast, Notch ICs lacking the C-terminal region also appear to be active in some contexts (Shawber et al., 1996; Wettstein et al., 1997) . Mammalian Notch signaling shows another level of complexity, as it was recently shown that the Notch 3 IC, in contrast to all other analyzed Notch receptors, is a very poor activator of HES promoters and in fact represses Notch 1 IC-mediated activation . A function for Notch 3 IC as a repressor of`classical' Notch signaling was demonstrated in vivo, by overexpressing Notch 3 IC in speci®c cell types in transgenic mice. Notch 3 IC expression in the developing CNS leads to a reduction of the level of HES-5 , and expression in progenitor cells of the developing pancreas leads to reduced HES-1 expression and precocious differentiation of endocrine cells (Apelqvist et al., 1999) . A similar effect in the pancreas was observed also in mouse embryos de®cient for RBP-Jk or the ligand Delta-1 (Apelqvist et al., 1999) .
The existence of two highly structurally similar but functionally divergent Notch ICs poses the question as to which domains in the receptors are responsible for the functional difference. The two Notch ICs provide an experimental opportunity to address this problem, as various chimeric receptors can easily be generated because of their high degree of similarity. In this report, we show that the ankyrin repeat region and a novel region, called the RE/AC (repression/activation) region, in the Notch IC are important for explaining the difference in function between Notch 1 IC and Notch 3 IC. The origin of the ankyrin repeat region, i.e. whether it is derived from Notch 1 or Notch 3 IC, determines the potency of the Notch IC as a transactivating factor. The RE/AC region de®nes a new transactivating domain for HES activation in Notch 1 IC, and the corresponding region in Notch 3 IC is important for Notch 3 IC's ability to repress Notch 1 IC in trans.
Results

Notch 3 IC can displace SMRT from RBP-Jk
It has previously been shown that an important step in Notch 1 IC-mediated activation of the HES-1 promoter is Notch 1 IC's displacement of the HDAC co-repressor SMRT from RBP-Jk (Kao et al., 1998) . A possible explanation for the poor activation capacity of Notch 3 IC could be that Notch 3 IC fails to displace SMRT. It has previously been demonstrated that Notch 3 IC can physically interact with RBP-Jk in vitro Kurooka et al., 1998) , but whether it could displace SMRT was never analyzed. To test this, we used a two-hybrid-based displacement assay, in which RBP-Jk was fused to the GAL4 DNAbinding domain and SMRT to the VP16 protein (Fig. 1A) . Co-expression of GAL4-RBP-Jk and VP16-SMRT resulted in activation from the UAS promoter, while expression of the constructs individually did not (Fig. 1B) . This shows that the interaction between RBP-Jk and SMRT can be recapitulated in this assay. When Notch 3 IC was expressed together with GAL4-RBP-Jk and VP16-SMRT, activation was reduced, indicating that Notch 3 IC, which does not activate via GAL4-RBP-Jk, replaces VP16-SMRT in the two-hybrid assay.
To corroborate this ®nding, we took advantage of the observation that Notch 3 IC activates the HES promoter to a low extent, albeit much lower than Notch 1 IC Kurooka et al., 1998) . We asked whether this low degree of activation could be eliminated by addition of SMRT. To this end, we co-transfected Notch 3 IC and RBP-Jk together with a SMRT expression construct. We found that the addition of SMRT suppresses the low degree of activation observed with only Notch 3 IC and RBP-Jk, which suggests that SMRT displaces Notch 3 IC from RBPJk (Fig. 1C) . When the experiment was performed with Notch 1 IC and RBP-Jk, addition of SMRT resulted in a strong repression of the HES promoter activity (Fig. 1C) , which is in keeping with SMRT displacing Notch 1 IC (Kao et al., 1998) . We conclude from these experiments that Notch 3 IC, like Notch 1 IC, is capable of displacing SMRT, and that Notch 3 IC's poor activation capacity is not a result of an inability to relieve repression and gain access to RBP-Jk in vivo.
Notch 3 IC can bind to SKIP
SKIP is a recently discovered integral part of the RBP-Jk RE/AC complex. It binds to RBP-Jk, provides a common and mutually exclusive binding surface for SMRT and Notch 1 IC, and facilitates Notch 1 IC function (Zhou et al., 2000) . Therefore, we wanted to learn whether SKIP interacted also with Notch 3 IC. To this end, a GST interaction assay to analyze the binding of GST-Notch 1 IC and GST-Notch 3 IC to 35 S-radiolabeled SKIP was performed ( Fig. 2A) . Both ICs appear to interact with SKIP with similar af®nities in this experiment. No unspeci®c interaction with GST alone could be detected. To substantiate this result we studied the interactions in vivo by a mammalian two-hybrid assay (Fig. 2B) . In this experiment, a clear interaction between GAL4-SKIP and VP16-Notch 3 IC was detected. In contrast, we observed only a very weak interaction between GAL4-SKIP and VP16-Notch 1 IC. This ®nding was unexpected, since a strong interaction was observed between SKIP and Notch 1 IC both in the GST pull-down experiment ( Fig. 2A ) and in the EBNA2-based two-hybrid system used by Zhou et al. (2000) . We currently can not explain the discrepancy between the results from the two different two-hybrid assays, but conclude that both Notch 3 IC and Notch 1 IC can interact with SKIP.
It has previously been proposed that Notch 3 IC's effective repression of Notch 1 IC-mediated activation may be due, at least in part, to competition for a nuclear factor that can bind to both proteins and which is present in limiting amounts . As Notch 3 IC and Notch 1 IC both bind to SKIP, it remains a possibility that Notch 3 IC could titrate out SKIP from Notch 1 IC if SKIP levels are limiting. To test this idea, we co-transfected Notch 1 IC and Notch 3 IC with increasing amounts of SKIP. As expected, Notch 3 IC repressed Notch 1 IC-mediated HES activation, but this repression was not relieved even by adding high amounts of SKIP (Fig. 2C ). This suggests that SKIP is not the factor for which Notch 1 IC and Notch 3 IC are competing.
Notch 3 IC can bind to PCAF
As Notch ICs can replace SMRT, it is an attractive hypothesis that the Notch ICs in addition recruit a histone acetyl transferase to revert hypoacetylation to hyperacetylation, thus rendering the chromatin accessible for transcrip- tion (Yang et al., 1996) . In a recent report, Notch 1 IC was shown to bind the histone acetyl transferase PCAF (Kurooka and Honjo, 2000) , and Notch 3 IC's poor activation could be a result of failure to bind PCAF. In Fig. 3A , it is shown that both GST-Notch 1 IC and GST-Notch 3 IC interact with 35 S-labeled PCAF, although the Notch 3 IC interaction was somewhat weaker. The interaction between Notch 3 IC and PCAF was corroborated by a two-hybrid experiment, in which the interaction between GAL4-PCAF and VP16-Notch 3 IC was tested. GAL4-PCAF alone resulted in four-fold activation, compared with mock transfection (Fig. 3B ). This is in contrast to a previous report (Kurooka and Honjo, 2000) , but could be explained by the use of different cell lines. Activation was elevated by a factor of two for GAL4-PCAF and VP16-Notch 3 IC, as compared to GAL4-PCAF alone (Fig. 3B ). The two-fold activation for Notch 3 IC should be compared to the seven-fold activation for GAL4-PCAF and VP16-Notch 1 IC reported by Kurooka and Honjo (2000) . The binding between GAL4-PCAF and VP16-Notch 3 IC could be effectively competed by the addition of a three-fold excess of free Notch 1 IC (Fig. 3B ), suggesting that Notch 1 IC and Notch 3 IC bind to the same site on PCAF. Taken together, these data support the view that both Notch 1 IC and Notch 3 IC interact with PCAF, although the interaction between Notch 3 IC and PCAF is somewhat weaker.
As for SKIP, the binding of PCAF to both Notch 1 IC and Notch 3 IC raised the possibility that PCAF would be the factor present in limiting supply, and that Notch 3 IC may titrate out PCAF from Notch 1 IC. This was tested by cotransfecting Notch 1 IC and Notch 3 IC with increasing amounts of GAL4-PCAF. No de-repression was observed 
A novel region is important for Notch 3 IC's repression in trans of Notch 1 IC-mediated activation
To further explore the molecular basis of Notch 3 IC repression, we analyzed the effects of deleting speci®c subdomains in the Notch 3 IC. As discussed in Section 1, a Notch IC can be divided into different regions: the RAM, ankyrin repeat and the C-terminal region. For reasons that will become apparent below, we also introduce a new region, the RE/AC region, which is located between the ankyrin repeats and the C-terminal region (Fig. 4A) . The RE/AC region in Notch 1 IC encompasses 118 amino acid residues, and in Notch 3 IC 125 amino acid residues. A comparison of the different regions between Notch 1 IC and Notch 3 IC reveals that the similarity is highest in the ankyrin repeat region (72% amino acid identity), while the RAM domain, RE/AC and the C-terminal regions have 41, 50 and 21% identity, respectively (Fig. 4A) .
We ®rst set out to identify the region in Notch 3 IC responsible for repression of Notch 1 IC-mediated activation. It has previously been shown that Notch 3 IC can ef®ciently repress in trans GAL4-Notch 1 IC from activating a UAS promoter . As discussed above, repression in trans is likely to be a result of the fact that Notch 1 IC and Notch 3 IC bind to the same nuclear factor, which is present in limiting amounts, and that interaction between Notch 3 IC and the nuclear factor does not lead to activation . Addition of Notch 3 IC would thus sequester this factor from Notch 1 IC, resulting in reduced activation. To identify the region in Notch 3 IC which is responsible for repression, we tested a series of Cterminal Notch 3 IC deletion constructs for their ability to repress GAL4-Notch 1 IC (for nomenclature of the various constructs, see the legend of Fig. 4) . The GAL4-Notch 1 IC construct (GAL4-1111) was co-transfected with an UASluciferase reporter construct and with Notch 3 IC (3333) or various deletion constructs thereof (Fig. 4B) . Addition of the 3333 construct led to a four-fold repression of activation from the UAS promoter. A construct where the complete (3330) C-terminal region was deleted was an equally potent repressor. In contrast, the 3300 construct, i.e. a Notch 3 IC lacking the RE/AC and the C-terminal regions, largely failed to repress the GAL4-1111-mediated activation (Fig. 4B) . To analyze if the same region was required for repression on a HES-1 promoter we tested the Notch 3 IC deletions on the HES-1 reporter (Fig. 4C) . A similar repression pattern was observed in this promoter context. To exclude the possibility that the lack of repression by 3300 was due to reduced expression, we measured the protein levels by Western blotting (Fig. 4D) . All constructs were expressed at similar levels and generated proteins of expected sizes. In 3330 and 3300 the C-terminal of the two NLS sequences has been removed. Thus, reduced repression could be a result of failure of nuclear translocation. We tested this by immunocytochemistry in transfected cells and we found that the different truncated forms of Notch 3 IC are located predominantly in the nucleus (Fig.  4E) .
These data suggest that the RE/AC region of Notch 3 IC is important for repression in trans, and to map this region in more detail, we tested deletion constructs which removed portions of the RE/AC region of Notch 3 IC. A full repressive effect was obtained only with the Notch 3 IC construct harboring the entire 125 amino acid residues long RE/AC region, and deletions within the RE/AC region caused a gradual loss of repression. A protein containing the RAM and ankyrin repeat region followed by 40 amino acid residues of the RE/AC region retains 50% repressive activity compared to 3330 (data not shown). While these experiments showed that the RE/AC region of Notch 3 IC was necessary for repression in trans, it remained to be determined whether it was suf®cient to mediate repression. To address this, we expressed constructs encompassing various portions of the RE/AC region and¯anking sequences. Constructs containing the RE/AC region linked to the two most C-terminal ankyrin repeats failed to repress, while the RE/AC region coupled to ankyrin repeats 3±6 showed good repression (Fig. 4B) . Taken together, we conclude that the RE/AC region in Notch 3 IC is necessary for repression in trans of Notch 1 IC-mediated activation, but that full repression requires also the presence of a part of the ankyrin repeat region. Transcriptional activation (lower) and protein expression levels (upper) of 1110 were compared in COS-7 cells; 100, 50, 20 and 10 ng of the 1110 expression plasmid were used. 1110 retains 60% of the transcriptional activity of 1111 when expressed at equivalent protein levels (compare transfection of 20 ng 1110 plasmid to 100 ng of 1111 plasmid). 1100 and 1101 are expressed at similar levels as 1111. The transactivation activities were measured as luciferase reporter activity relative to 1111 activity (100%). ##P , 0:001 vs. mock; **P , 0:001 vs. 1111. (D) Immunocytochemistry in C2C12 cells using anti-myc antibody shows that the Notch 1 IC deletion mutants retain their nuclear localization. (E) GAL4-1101 interacts with VP16-RBP in a mammalian two-hybrid assay. Some activity can also be observed for GAL4-1101 and VP16, although much lower than for GAL4-1101 and VP16-RBP. No interaction was observed between GAL4 and VP16 alone. Bars represent fold activation of the UAS-luciferase reporter. ##P , 0:001 vs. GAL4 1 VP16. The DNA levels were constant in all transfections and vector alone was used as mock. The data shown represent the mean of three independent experiments performed in triplicate.
The RE/AC region is important for Notch 1 IC-mediated activation of HES promoters
In light of the importance for the Notch 3 RE/AC region for repression in trans, presumably by competition for a common factor, it could be surmised that the corresponding region in Notch 1 IC would play a role in activation. To test this idea, we analyzed the importance of the individual domains in Notch 1 IC for activation of the HES-1 promoter. The data show that the construct in which the C-terminal region of Notch 1 IC was removed, i.e. the 1110 construct, was equally as potent as 1111 as an activator (Fig. 5A) . In contrast, the 1100 construct, lacking both the RE/AC and Cterminal regions, has largely lost the activation capacity (4% activation compared to 1111). This identi®es the Notch 1 RE/AC region as critical for activation. To further test this, we analyzed the construct 1101, which contains the RAM, ankyrin repeat and C-terminal regions, and speci®cally lacks the RE/AC region. This modi®ed Notch 1 IC, 1101, completely lacks transactivation activity (Fig. 5A ). Since the HES-5 gene is also regulated by Notch signaling de la Pompa et al., 1997) , we tested the Notch 1 IC deletion constructs also on this promoter. The 1111 and 1110 constructs were robust activators, while the 1100 and 1101 constructs were considerably weaker (Fig. 5B ), in keeping with the HES-1 data.
To further analyze the activation potency of 1110, we measured activation from transfections of varying amounts of 1110 (Fig. 5C ). At protein levels comparable to those of 1111, 60% of the activity of 1111 was observed for 1110 (Fig. 5C, lane 4) . Interestingly, even very low levels of 1110, which are barely detected by Western blotting (Fig.  5C, lane 5) , showed approximately 60% of the activation of 1111. This observation is in keeping with previous data from Kopan et al. (1996) showing that very low amounts of Notch 1 IC lead to HES promoter activation. Nuclear localization of the mutant proteins was analyzed by immunocytochemistry. The encoded proteins were detected in the nucleus, although some staining could be seen also in the cytoplasm (Fig. 5D) . To rule out the possibility that the 1101 construct had lost its RBP-Jk binding capacity, we showed that the GAL4-1101 could interact with VP16-RBP-Jk in a two-hybrid assay (Fig. 5E) . Taken together, the data shown here indicate that the C-terminal region contributes to some of the transcriptional activity on the HES promoters, but that the 118 amino acid residues long region in the RE/AC domain of Notch 1 IC is critical for activation.
This observation differs from previous reports, where the C-terminal region of Notch 1 IC was shown to be critical for activation (Kurooka and Honjo, 2000; Kurooka et al., 1998) . The difference may be attributed to the use of somewhat different promoter contexts. In this study, a 250 bp region from the endogenous HES-1 promoter was used (Jarriault et al., 1995; Takebayashi et al., 1994) , while in the other studies a hexamerized 50 bp DNA sequence (EBNA2RE) of the TP-1 promoter was used. Therefore, we tested the importance of the various Notch 1 IC domains in yet another promoter context. Various Notch 1 IC deletion constructs Fig. 6 . The repressive capacity of Notch 3 IC deletion mutants on different GAL4-Notch 1 IC fusion constructs. Transfection of GAL4-fusion constructs of 0001 and 0011 results in 103-and 52-fold activation of the UAS reporter in COS-7 cells, respectively. Both constructs can be repressed by 3333, 3330 or 3300. GAL4-1101 is a weak activator (®ve-fold) and GAL4-0010 does not activate at all. The activation levels of GAL4-1101 and GAL4-0010 are not signi®cantly altered by addition of 3333, 3330 and 3300. ##P , 0:001, #P , 0:05 vs. mock; **P , 0:001 vs. GAL4-0001; § §P , 0:001, §P , 0:05 vs. GAL4-0011. The DNA levels were constant in all transfections and vector alone was used as mock. The data shown represent the mean of three independent experiments performed in triplicate.
were fused to the coding region for the GAL4 DNA-binding domain and tested for activity on the UAS promoter element (Fig. 6, lanes 1, 5, 9 and 13 ). In agreement with previous data (Kurooka and Honjo, 2000; Kurooka et al., 1998) , GAL4-0001 is a strong activator of UAS-luciferase (103-fold activation) (Fig. 6, lane 1) . GAL4-0011 is also an activator, albeit less potent (Fig. 6, lane 5) . In contrast, GAL4-0010 failed to activate UAS-luciferase and GAL4-1101 was a poor activator (Fig. 6, lanes 9 and 13, respectively) . We next tested whether the activity of the GAL4-Notch 1 IC constructs could be repressed by particular regions in Notch 3 IC. When GAL4-0001 was co-expressed with 3333, 3330 or 3300, the activity was signi®cantly reduced (Fig. 6, lanes  2±4) , and similar results were obtained for GAL4-0011 (Fig.  6, lanes 6±8) . In both cases, 3333 was the most potent repressor, followed by 3330 and 3300. The low level of activation observed from GAL4-0010 and GAL4-1101 was not altered by the addition of 3333, 3330 or 3300. It was unexpected to ®nd that the 3300 construct could repress GAL4-0001 since the 3300 construct lacks the C-terminal region. We can not explain this, but an interesting possibility is that a factor may bind to more than one domain in a Notch IC and thus could be titrated out by a domain different from the one present in the activating construct. A binding to both the C-terminal and the ankyrin repeat region has, for example, been demonstrated for PCAF (Kurooka and Honjo, 2000) . We conclude from these data that the GAL4 promoter situation differs from the HES promoter context, and that the C-terminal region is a more potent activator on the GAL4 promoter as compared to the 250 bp HES-1 promoter construct. Furthermore, the C-terminal region is not an activator in the 1101 setting, but here requires the RE/AC domain (compare GAL4-1101 with GAL4-1111 and GAL4-0011).
The origin of the ankyrin repeats is important for the extent of activation from the HES promoter
As discussed above, the RE/AC region is important both for Notch 1 IC-mediated activation and for Notch 3 ICmediated repression in trans. The ®nding that both Notch 1 IC and Notch 3 IC contain an RE/AC region, and presumably can bind the same factor, does not, however, explain why Notch 1 IC is a far better activator on the HES promoter than Notch 3 IC. Therefore, we investigated whether the origin of a particular region in the IC, i.e. whether it was derived from Notch 1 IC or Notch 3 IC, was critical for the extent of activation from a HES promoter. In the ®rst set of experiments (Fig. 7A) , we used the 1111 construct as à backbone', and replaced various regions with the corresponding regions of Notch 3 IC origin (see also Fig. 8D for a schematic depiction of the various chimeric constructs). Replacement of the C-terminal region (1113) or both the C-terminal and RE/AC regions (1133) did not signi®cantly reduce the transcriptional activity as compared to 1111. Removal of the C-terminal region alone (1110) or in combination with replacing the RE/AC region (1130) also did not reduce the activation. The somewhat higher activity of 1110 is probably due to higher expression levels (see Fig.  7D , compare also Fig. 5C ). In a converse experiment (Fig.  7B) , we wanted to learn whether the transcriptional activity of Notch 3 IC could be improved by replacing different regions with the corresponding Notch 1-derived regions, starting with Notch 3 IC (3333) as the`backbone'. Replacement of the C-terminal and/or RE/AC regions (3331 and 3311) improved transcriptional activation approximately two-fold, but was still low compared to 1111 (Fig. 7B) . The deletion of the C-terminal region, with or without replacement of the RE/AC region (3330 and 3310), did not signi®cantly increase activation. All proteins were expressed at similar levels (Fig. 7D) .
Since the difference in activation and/or repression did not appear to be a consequence of the origin of the RE/AC and C-terminal regions, we generated a new set of chimeric Notch 1/3 IC constructs to test the role of the ankyrin repeat region (Fig. 7C) . As the C-terminal region had little effect on transactivation on the HES promoter, we made chimeric constructs composed of only the RAM, ankyrin repeat and RE/AC regions. Strikingly, a construct consisting of the RAM and RE/AC regions from Notch 1 IC with an ankyrin repeat region from Notch 3 IC (1310) was a poor activator, comparable to the 3333 and 3330 constructs. In contrast, the converse construct, i.e. containing the RAM and RE/AC regions from Notch 3 IC and the ankyrin repeat region from Notch 1 IC (3130), was a considerably better activator, and very close to 1111 in activity (Fig. 7C) . These data strongly argue that the origin of the ankyrin repeat region is of critical importance for the level of activation of the HES-1 promoter.
The origin of the ankyrin repeat region is important also for repression in trans
In Fig. 4 , we showed that the presence of the RE/AC domain was critical for Notch 3 IC's ability to repress Notch 1 IC-mediated activation in trans, but the relative importance of the origin of the different regions for repression was not addressed. Therefore, we tested the set of chimeric Notch ICs used in Fig. 7 (schematically depicted in Fig. 8D ) for their ability to repress activation from GAL4-1111. As expected, 1111 was a less potent repressor than 3333 (Fig. 8A) . All constructs containing the Notch 1 RAM and ankyrin repeat regions, i.e. 1113, 1133, 1110 and 1130, repressed to the same extent as 1111 (26±49% repression), as compared to the 84% repression observed for 3333 (Fig.  8A) . In contrast, chimeric ICs containing the Notch 3 RAM and ankyrin repeat regions, i.e. 3331, 3311, 3330 and 3310, repress GAL4-1111 as well as 3333 (Fig. 8B) . The 1310 chimeric IC repressed GAL4-1111 even better than 3333, while the converse construct, 3130, displayed a reduced repression activity, comparable to that of 1111 and 1110. A very similar repression pattern was observed on the HES promoter using 1111 as an activator, i.e. chimeric IC molecules containing the RAM and ankyrin repeat regions from Notch 3 were good repressors (data not shown). For technical reasons, constructs containing RAM and ankyrin of Notch 1 origin could not be tested, since they are too potent activators on their own. Collectively, these data demonstrate that the origin of the ankyrin repeat region is important not only for activation, but also for repression in trans.
Discussion
Individual members of the mammalian Notch receptor family differ in their capacity to activate HES genes, which is the best understood signaling response downstream of the Notch receptor. Notch 1 and Notch 2 act as activators of HES signaling, and Drosophila Notch similarly activates the HES homologue Enhancer of Split (Hsieh et al., 1997; Rebay et al., 1993; Struhl et al., 1993) . In contrast, the Notch 3 IC is a poor activator of HES transcription and it represses Notch 1 IC-mediated activation in certain contexts . Expression of Notch 3 IC in vivo demonstrates a similar repressive effect on HES signaling in the developing CNS and pancreas (Apelqvist et al., 1999; Beatus et al., 1999;  for review see Kadesch, 2000) . In the latter case this leads to the same type of divergence of cell fate as observed after removal of the Delta-1 ligand or RBP-Jk (Apelqvist et al., 1999) . However, two recent reports indicate that Notch 3 IC in some situations may behave differently. Recent work by Tanigaki et al. (2001) shows that Notch 3 IC functions similarly to Notch 1 IC in adult CNS stem cells in terms of upregulating HES-1 expression and inducing astrocytic differentiation. Furthermore, ectopically expressed Notch 3 IC induces HES-1 expression in immature thymocytes in transgenic mice (Bellavia et al., 2000) . However, the observed phenotype is different from that obtained by ectopic expression of Notch 1 IC (Bellavia et al., 2000) . In this study, we have begun to explore the molecular differences underlying the different signaling capacity from the two structurally highly conserved Notch 1 and Notch 3 ICs.
The RE/AC region is important for Notch IC regulation of HES promoters
Previous work on Notch ICs has focused on three different domains: the RAM, ankyrin repeat and C-terminal regions. Here, we describe another region in the Notch IC, the RE/AC region, and show that it is important for regulation of HES promoters. Several lines of evidence support the importance of the RE/AC region, which is a 120 amino acid residues long region located immediately C-terminal of the ankyrin repeat region. In Notch 1 IC, deletion constructs in which only the RE/AC region is removed fail to activate transcription, while more C-terminal deletions result in a much less dramatic decrease in activation. Similarly, removal of the RE/AC region from Notch 1 IC fused to GAL4 DB (G4-1101) largely abolished activation from a GAL4 responsive promoter. In Notch 3 IC, the RE/AC region is also important, but here it plays a critical role in repression in trans of Notch 1 IC-mediated activation of the HES-1 promoter. Deletion constructs of Notch 3 IC, where the RE/AC region is removed, largely fail to repress Notch 1 IC-mediated activation on HES promoters. Moreover, a small region encompassing the Notch 3 IC RE/AC region, together with the last four ankyrin repeats, is suf®cient to mediate substantial repression. The importance of this region has been shown in ESR-1 activation in Xenopus (Wettstein et al., 1997) , in activation of the TP-1 promoter (Kurooka and Honjo, 2000) and for cellular transformation (Jeffries and Capobianco, 2000) . Furthermore, it has been shown that Notch 1 IC and Notch 2 IC inhibit myeloid differentiation in response to different cytokines and that a region corresponding to RE/AC is involved in mediating the cytokine speci®city of Notch 1 IC and Notch 2 IC (Bigas et al., 1998) . The ®nding that the RE/AC region is crucial for HES promoter regulation, oncogenesis and cytokine speci®city underlines its importance for Notch function in various contexts.
It has previously been proposed that the Notch 3 ICmediated repression of Notch 1 IC activation is caused both by competition for access to RBP-Jk and by competition for a nuclear factor present in limiting amounts . The most parsimonial explanation for the role of the RE/AC region is to postulate that it constitutes a binding domain for the putative factor present in limiting amounts. This line of reasoning receives support from the ®nding that the Notch 3 IC RE/AC region can replace the Notch 1 IC RE/ AC region in the full IC context (compare constructs 1113 and 1133 in Figs. 7 and 8) . It is interesting to note that there are local stretches of very high amino acid sequence similarity when the RE/AC regions of Notch 1 and Notch 3 ICs are compared. However, these highly conserved domains are not binding sites for known transcription factors.
The C-terminal region of Notch 1 IC functions as a transcriptional activator on a multimerized RBP-Jk binding site, and has consequently also been referred to as TAD (transcription activation domain) (Kurooka et al., 1998) . The Cterminal region, alone or with the RE/AC region, is a potent activator also on the GAL4 responsive promoter (Fig. 6 ), in keeping with previous data (Kurooka et al., 1998) . In contrast, we found that the C-terminal region of Notch 1 IC was dispensable for potent activation on an endogenous 250 bp HES promoter. This indicates that the C-terminal region is crucial only on the multimerized RBP-Jk binding sites and in the GAL4 context, but not on the endogenous HES promoter.
3.2. The origin of the ankyrin repeat region is critical for the ability of a Notch IC to serve as an activator or repressor While the presence of a RE/AC region is required for activation from Notch 1 IC and repression from Notch 3 IC, the origin of the RE/AC region is not important for activation, since it can be exchanged between the two ICs without altering the effect. The RE/AC region does therefore per se not explain why Notch 1 IC is a good activator and Notch 3 IC is not. To address whether the origin of other regions was important, a set of chimeric Notch 1 IC/Notch 3 IC molecules was tested for activation and repression. We conclude that the origin of the ankyrin repeat region was the most critical determinant for activation from HES promoters. This is based on the observation that only chimeric ICs containing the ankyrin repeat region from Notch 1 were good activators, while Notch 3 ankyrin repeat-containing constructs were not (Fig. 7) . The origin of the ankyrin repeat region was also most important for repression in trans. Only chimeric ICs harboring Notch 3 IC-derived ankyrin repeats were repressors of the same magnitude as 3333, while proteins with ankyrin repeats derived from Notch 1 were considerably less potent repressors (Fig. 8) .
How can the data presented here be incorporated into a model explaining the difference in HES promoter activation by Notch 1 and Notch 3? There could be two principally different explanations for Notch 3 IC's poor activation capacity. First, Notch 3 IC may not get access to RBP-Jk on the HES promoter in vivo or, second, something in the structure of Notch 3 IC makes it an inferior activator once positioned on the HES promoter. The ®rst explanation appears less likely, based on the data from the SMRT and SKIP experiments (Figs. 1±3) . We show that Notch 3 IC, like Notch 1 IC (Kao et al., 1998) , is capable of displacing VP16-SMRT from RBP-Jk fused to GAL4 in a two-hybrid assay. Furthermore, addition of SMRT to both Notch 1 IC and Notch 3 IC results in repression of activation on the HES promoter; in the case of Notch 1 IC a dramatic decrease, and in the case of Notch 3 IC a decrease from a very low level of activation. We also observed that both Notch 1 IC and Notch 3 IC can bind to SKIP, which facilitates Notch function and has been shown to bind Notch 1 IC and SMRT in a mutually exclusive manner (Zhou et al., 2000) . In conclusion, it therefore appears reasonable to assume that Notch 3 IC can access RBP-Jk on a HES promoter in a manner similar to Notch 1 IC, i.e. by displacing SMRT from binding to SKIP/RBP-Jk.
Assuming that both Notch 1 IC and Notch 3 IC have access to RBP-Jk in vivo, we propose three different models to explain the differences in activation (Fig. 9 ). These models take into account that the origin of the ankyrin repeat regions is important and that a Notch IC requires the presence of a RE/AC region, which binds a factor, present in limiting amounts. In the ®rst model (Fig. 9A) , the ankyrin repeat region would be important for the conformation of the Notch IC/factor complex, and the factor binding to the RE/AC region would only be optimally presented to the transcription machinery when the ankyrin repeat region is of Notch 1 IC origin. In the second model (Fig. 9B) , the ankyrin repeat region of Notch 1 IC serves as a docking site for a second co-activator, which can not bind or binds less well to the ankyrin repeat region of Notch 3 IC. Only the cooperative binding of the co-activator on the Notch 1 IC ankyrin repeats and the factor binding to the RE/AC region would lead to potent activation. PCAF binds less well to Notch 3 IC than to Notch 1 IC, and could thus be a candidate factor in Fig. 9B . PCAF has indeed been shown to bind both to the ankyrin repeats and the C-terminal region in Notch 1 IC (Kurooka et al., 1998) . The less ef®cient PCAF binding to Notch 3 IC could result in a more compacted chromatin structure at the promoter, as compared to when Notch 1 IC-PCAF is present. In the third model (Fig. 9C) , the presence of an additional factor is also postulated, but in this model the co-factor would be a co-repressor speci®cally recruited to the Notch 3 IC ankyrin repeat region. This could quench the activity of the factor binding to the RE/AC region, thus rendering Notch 3 IC incapable of activating transcription.
Irrespective of the ®ner details of how different factors work together to ®ne-tune transcriptional regulation, the discovery of the novel RE/AC region in the Notch IC is important for a more complete understanding of Notch signal transduction. The RE/AC region, combined with the observation that the origin of the ankyrin repeat region is important for activation, helps to explain why different Notch ICs are endowed with different activation properties on downstream HES promoters.
Experimental procedures
DNA constructs and cloning
The pCMX-hSMRT construct was a kind gift from Dr T. Fig. 9 . Three models to explain the difference in activation from the HES promoter between Notch 1 IC and Notch 3 IC are presented. (A) A co-activator (dotted) binds to the RE/AC region of Notch 1 IC (horizontal bar) and results in HES promoter activation (RBP-Jk is represented by a striped circle). Notch 3 IC, however, acquires a conformation, based on the presence of a Notch 3 IC-derived ankyrin repeat, which removes the effect of the co-activator. (B) The coactivator (dotted) binds to both Notch 1 IC and Notch 3 IC, but is not suf®cient for activation. In addition, a second co-activator (circle with a plus sign) binds speci®cally to the ankyrin repeat of Notch 1 IC, and together the co-activators mediate activation of transcription. (C) The co-activator (dotted) binds to both Notch 1 IC and Notch 3 IC, and is suf®cient for activation. Notch 3 IC, however, in addition binds a co-repressor (circle with minus sign) to the ankyrin repeat region, which quenches the effect of the co-activator.
were induced and extracted according to the manufacturer's instructions (Pharmacia Biotech).
35
S-labeled PCAF was synthesized in vitro using the TNT-coupled rabbit reticulocyte lysate system (Promega).
S-labeled PCAF was mixed with equal amounts of GST-Notch 1 IC, GST-Notch 3 IC or GST and incubated for 1 h at 48C in 200 ml G-buffer (20 mM Tris±HCl (pH 7.9), 150 mM KCl, 1 mM EDTA, 4 mM MgCl 2 , 0.2% Nonidet P-40 and 10% glycerol). Proteins were washed six times in G-buffer, released in 2£ sample buffer (2% SDS, 10% glycerol, 80 mM Tris (pH 6.8), 0.72 M b-mercaptoethanol and 0.02% Bromophenol Blue) and analyzed by SDS-PAGE and autoradiography.
